Atıf Formatları
Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. Eskiyurt Et Al. , "Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old," Annual Meeting of the American-Society-for-Bone-and-Mineral-Research , vol.28, Maryland, United States Of America, 2013

Eskiyurt, N. Et Al. 2013. Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old. Annual Meeting of the American-Society-for-Bone-and-Mineral-Research , (Maryland, United States Of America).

Eskiyurt, N., Gunaydin, R., Erhan, B., Bodur, H., KIRNAP, M., Sepici, V., ... Kuran, B.(2013). Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old . Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Maryland, United States Of America

Eskiyurt, Nurten Et Al. "Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old," Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Maryland, United States Of America, 2013

Eskiyurt, Nurten Et Al. "Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old." Annual Meeting of the American-Society-for-Bone-and-Mineral-Research , Maryland, United States Of America, 2013

Eskiyurt, N. Et Al. (2013) . "Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old." Annual Meeting of the American-Society-for-Bone-and-Mineral-Research , Maryland, United States Of America.

@conferencepaper{conferencepaper, author={Nurten Eskiyurt Et Al. }, title={Efficacy and Safety of Zoledronic Acid in Postmenopausal Osteoporosis Patients Between 50-65 Years Old}, congress name={Annual Meeting of the American-Society-for-Bone-and-Mineral-Research}, city={Maryland}, country={United States Of America}, year={2013}}